On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed below.
Here’s why these brokers are bearish on them:
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)
According to a note out of Citi, its analysts have retained their sell rating but increased the price target on this medical device company’s shares to NZ$26.25 (A$24.95). This follows the release of its half year results on Wednesday. Although the broker was impressed with its result and believes its Hospital segment is well-placed for very strong growth over the 2020s, it has issues with its valuation and believes its shares are overvalued. The Fisher & Paykel Healthcare share price is trading at $31.07 this afternoon.
Magellan Financial Group Ltd (ASX: MFG)
Analysts at Morgan Stanley have retained their underweight rating and $48.00 price target on this fund manager’s shares. According to the note, given Magellan’s focus on growth, it has concerns that its performance could be impacted by the recent rotation to value options. It doesn’t believe this has been factored into the current share price and fears there could be downside risk in the near term. The Magellan share price is changing hands for $61.09 today.
Xero Limited (ASX: XRO)
A note out of UBS reveals that its analysts have retained their sell rating and $77.00 price target on this cloud-based business and accounting software platform provider’s shares. This follows the announcement of a US$600 million (later upsized to US$700 million) convertible notes offering. UBS was surprised by the size of the offering and believes it could be a sign that a significant acquisition is coming. While this has the potential to be a positive, it isn’t enough for a change of rating. UBS believes its shares are still overvalued at the current level. The Xero share price is trading at $133.06 this afternoon.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
More reading
- Broker tips Fisher & Paykel Healthcare (ASX:FPH) share price to go even higher
- ASX stock of the day: Platinum (ASX:PTM) shares up 6%
- 3 ASX shares with large dividend yields
- ASX 200 up 0.8%: Fisher & Paykel Healthcare impresses, Harvey Norman’s profits surge
- Why Mesoblast, Temple & Webster, Xero, & Zip shares are dropping lower
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Top brokers name 3 ASX shares to sell today appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3m9xlau
Leave a Reply